Liesveld JL - Search Results

1

Evolution of acute myelogenous leukemia stem cell properties after treatment and progression.

Ho TC, LaMere M, Stevens BM, Ashton JM, Myers JR, O'Dwyer KM, Liesveld JL, Mendler JH, Guzman M, Morrissette JD, Zhao J, Wang ES, Wetzler M, Jordan CT, Becker MW. Ho TC, et al. Among authors: liesveld jl. Blood. 2016 Sep 29;128(13):1671-8. doi: 10.1182/blood-2016-02-695312. Epub 2016 Jul 15. Blood. 2016. PMID: 27421961 Free PMC article.

2

Expression of integrins and examination of their adhesive function in normal and leukemic hematopoietic cells.

Liesveld JL, Winslow JM, Frediani KE, Ryan DH, Abboud CN. Liesveld JL, et al. Blood. 1993 Jan 1;81(1):112-21. Blood. 1993. PMID: 7678062 Free article.

3

Effects of GM-CSF on Ki67 expression and cell cycle traverse in acute myelogenous leukemia specimens and cell lines.

Liesveld JL, Keng PC, Rowe JM, DiPersio JF, Abboud CN. Liesveld JL, et al. Leuk Res. 1994 Aug;18(8):609-16. doi: 10.1016/0145-2126(94)90042-6. Leuk Res. 1994. PMID: 8065162

4

Expression and function of adhesion receptors in acute myelogenous leukemia: parallels with normal erythroid and myeloid progenitors.

Liesveld JL. Liesveld JL. Acta Haematol. 1997;97(1-2):53-62. doi: 10.1159/000203659. Acta Haematol. 1997. PMID: 8980610 Review.

5

Expression of interleukin-7 receptor by lineage-negative human bone marrow progenitors with enhanced lymphoid proliferative potential and B-lineage differentiation capacity.

Ryan DH, Nuccie BL, Ritterman I, Liesveld JL, Abboud CN, Insel RA. Ryan DH, et al. Among authors: liesveld jl. Blood. 1997 Feb 1;89(3):929-40. Blood. 1997. PMID: 9028324 Free article.

6

The hematopoietic stem cell in myelodysplasia.

Liesveld JL, Jordan CT, Phillips GL 2nd. Liesveld JL, et al. Stem Cells. 2004;22(4):590-9. doi: 10.1634/stemcells.22-4-590. Stem Cells. 2004. PMID: 15277704 Review.

7

Acute myelogenous leukemia--microenvironment interactions: role of endothelial cells and proteasome inhibition.

Liesveld JL, Rosell KE, Lu C, Bechelli J, Phillips G, Lancet JE, Abboud CN. Liesveld JL, et al. Hematology. 2005 Dec;10(6):483-94. doi: 10.1080/10245330500233452. Hematology. 2005. PMID: 16321813 Free article.

8

A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia.

Lancet JE, Gojo I, Gotlib J, Feldman EJ, Greer J, Liesveld JL, Bruzek LM, Morris L, Park Y, Adjei AA, Kaufmann SH, Garrett-Mayer E, Greenberg PL, Wright JJ, Karp JE. Lancet JE, et al. Among authors: liesveld jl. Blood. 2007 Feb 15;109(4):1387-94. doi: 10.1182/blood-2006-04-014357. Epub 2006 Nov 2. Blood. 2007. PMID: 17082323 Free PMC article. Clinical Trial.

9

Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cells.

Liesveld JL, Bechelli J, Rosell K, Lu C, Bridger G, Phillips G 2nd, Abboud CN. Liesveld JL, et al. Leuk Res. 2007 Nov;31(11):1553-63. doi: 10.1016/j.leukres.2007.02.017. Epub 2007 Apr 2. Leuk Res. 2007. PMID: 17403536 Free PMC article.

10

Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8).

Guzman ML, Li X, Corbett CA, Rossi RM, Bushnell T, Liesveld JL, Hébert J, Young F, Jordan CT. Guzman ML, et al. Among authors: liesveld jl. Blood. 2007 Dec 15;110(13):4436-44. doi: 10.1182/blood-2007-05-088815. Epub 2007 Sep 4. Blood. 2007. PMID: 17785584 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters